2024 Umbilical Cord Blood Transplantation for Fanconi Anemia with a special focus on late complications: a Study on Behalf of Eurocord and SAAWP-EBMT Group Severe Aplastic Anaemia Working Party (SAAWP) 1st listed author Hanadi Rafii Journal Transplant Cell Ther.
2024 Incidence and outcome of central nervous system relapse after hematopoietic stem cell transplantation in patients suffering from acute myeloid leukemia and acute lymphoblastic leukemia: a study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation Group Acute Leukemia Working Party (ALWP) 1st listed author Sabine Blum Journal Haematologica.
2024 Hematopoietic cell transplantation and cellular therapies in Europe 2022. CAR-T activity continues to grow; transplant activity has slowed: a report from the EBMT Group Activity survey office 1st listed author Jakob R. Passweg Journal Bone Marrow Transplant.
2024 Current challenges in cell and gene therapy: a joint view from the European Committee of the International Society for Cell & Gene Therapy (ISCT) and the European Society for Blood and Marrow Transplantation (EBMT) 1st listed author Fermin Sanchez-Guijo Journal Cytotherapy.
2024 Innovative cellular therapies for autoimmune diseases: expert-based position statement and clinical practice recommendations from the EBMT practice harmonization and guidelines committee Group Autoimmune Diseases Working Party (ADWP) Practice Harmonisation and Guidelines Committee 1st listed author Raffaella Greco Journal EClinicalMedicine.
2024 Allogeneic hematopoietic cell transplantation for acute myeloid leukemia with hyperdiploid complex karyotype Group Acute Leukemia Working Party (ALWP) 1st listed author Xavier Poiré Journal Bone Marrow Transplant.
2024 Hematopoietic stem cell transplantation for pediatric patients with non-anaplastic peripheral T-cell lymphoma. An EBMT pediatric diseases working party study Group Paediatric Diseases Working Party (PDWP) 1st listed author Olga Moser Journal Bone Marrow Transplant.
2024 In the era of Bortezomib-based Induction, intensification of Melphalan-based conditioning with Bortezomib does not improve Survival Outcomes in newly diagnosed Multiple Myeloma: a study from the Chronic Malignancies Working Party of the EBMT Group Chronic Malignancies Working Party (CMWP) 1st listed author Meral Beksac Journal Bone Marrow Transplant.
2024 Impact of post-transplant cyclophosphamide (PTCy)-based prophylaxis in matched sibling donor allogeneic haematopoietic cell transplantation for patients with myelodysplastic syndrome: a retrospective study on behalf of the Chronic Malignancies Working Party of the EBMT Group Chronic Malignancies Working Party (CMWP) 1st listed author María Queralt Salas Journal Bone Marrow Transplant.
2024 Cytogenetic abnormalities predict survival after allogeneic hematopoietic stem cell transplantation for pediatric acute myeloid leukemia: a PDWP/EBMT study Group Paediatric Diseases Working Party (PDWP) 1st listed author Akshay Sharma Journal Bone Marrow Transplant.
2024 Allogeneic hematopoietic cell transplantation is equally effective in secondary acute lymphoblastic leukemia (ALL) compared to de-novo ALL-a report from the EBMT registry Group Acute Leukemia Working Party (ALWP) 1st listed author A Sadowska-Klasa Journal Bone Marrow Transplant.
2024 Indication and management of allogeneic haematopoietic stem-cell transplantation in myelofibrosis: updated recommendations by the EBMT/ELN International Working Group Group Chronic Malignancies Working Party (CMWP) 1st listed author Nicolaus Kröger Journal Lancet Haematol.